About BNCT

Boron Neutron Capture Therapy is a cancer treatment of cellular targeted heavy-ion therapy. It has demonstrated compelling responses for recurrent or refractory cancers, including head and neck cancers, glioblastoma, osteosarcoma, melanoma, liver caners and has been successful in treating cancer patients for whom other treatment options have been exhausted.

Principle
Benefits
Indications

Technology Knowledge

Principle
Benefits
Indications

Focus on cancer treatment
for Innovation Precision Efficiency

Established in 2014, Neuboron is the first and the only total solution provider and manufacture of AB-BNCT on earth.

National key projects

3+

National key projects

Patent application

500+

Patent application

1st AB-BNCT center in China

1st

1st AB-BNCT center in China

Our total solution in AB-BNCT

We have internationally exclusive and advanced technologies including accelerator-based BNCT system, treatment planning software with independent Monte Carol engine, patient positioning system, facility design, and targeted boron drugs.

AB-BNCT System
Targeted Boron Drugs
Treatment Planning Software
Technical Service
AB-BNCT System
Targeted Boron Drugs
Treatment Planning Software
Technical Service